This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Cosette Pharmaceuticals, Inc. Upon close, Cosette will market 12 patent-protected products focused on womens health and dermatology, including leading brands such as Rhofade (oxymetazoline topical)and several programs in clinical development. is acquiring Mayne Pharma. share for a total consideration of approximately USD $430 Million.
Phyllis Hsieh is the visionary behind Conrex Pharmaceutical Corp. and the creator of SESHA SKIN THERAPY, a professional skincare brand powered by Patented enhancement technology (P.E.T ) technology. The Permeation Enhancement Technology is FDA-approved in pharmaceuticals.
Several new therapies are coming down the pike for the treatment of lichen planus, a chronic inflammatory condition that affects an estimated 1% to 2% of the global population, according to a new report from Research and Markets. Similarly, Incyte and AFYX Therapeutics are developing new therapeutics for lichen planus.
Jashin Wu, MD, founder and CEO of the Dermatology Research and Education Foundation in San Diego, CA, says that more psoriasis patients will see improvements in their condition due to the influx of new agents and biosimilars on the market. Dupilumab (Dupixent, Regeneron Pharmaceuticals, Inc., And the Skin Disease of the Year Is….
Verrica Pharmaceuticals Inc. has entered into an amendment to its existing licensing agreement with Torii Pharmaceutical Co. alone and no FDA approved therapies, common warts represent one of the largest unmet needs in all of dermatology. With a prevalence of approximately 22 million patients in the U.S.
The Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing authorization for dupilumab (Dupixent, Sanofi and Regeneron Pharmaceuticals, Inc.) for the treatment of chronic spontaneous urticaria (CSU) in people aged 12 years and older whose disease is not adequately controlled with existing therapy.
Launching Uzpruvo at the earliest opportunity in Europe’s largest pharmaceuticalmarkets, promotes access by creating competition,” says STADA CEO Peter Goldschmidt in a news release. We are delighted at the launch of Uzpruvo in Europe and to be first-to-market,” adds Robert Wessman, Chief Executive Officer of Alvotech.
So, pharmaceutical companies are spending money researching this. As you can imagine, this would be a huge market if someone found something that actually worked. I can tell you, the solution is not going to come from a Multilevel marketing company. And a product like this would be a drug. I feel your pain.
AD: New topicals for kids “The most exciting new research is in the realm of topical therapies for atopic dermatitis (AD) in children,” shares Peter A. We will hopefully see at least one new biologic agent enter the market for AD, perhaps two,” he says. “We There’s more to look forward to as well, Dr. Lio says. “We
AD: New topicals for kids “The most exciting new research is in the realm of topical therapies for atopic dermatitis (AD) in children,” shares Peter A. We will hopefully see at least one new biologic agent enter the market for AD, perhaps two,” he says. “We There’s more to look forward to as well, Dr. Lio says. “We
The Link Between Dementia and Common Drugs Psychiatrist Dr. Peter Breggin, who has published several books on psychopharmacology, told The Epoch Times that most drugs on the market have some degree of neurotoxicity, which can lead to cognitive and neurological side effects. Risacher and her co-authors wrote in a JAMA Neurology study.
However, the connection between beauty culture and pharmaceutical interventions is one that demands critical examination. The Beauty Culture Connection From commercial marketing to social media platforms, we are bombarded with images of the most coveted and idealized flawless skin, plump lips, and slim bodies.
GLP-1’s unique ability to affect both glucose metabolism and appetite makes it a critical hormone in weight management and a target for pharmaceutical treatments aimed at curbing hunger and improving metabolic health. At the same time, GLP-1 signals to the brain that the stomach is full, helping to suppress appetite.
A cosmeceutical is essentially a skincare product that contains a biologically active compound that is thought to have pharmaceutical effects on the skin. Both pharmaceutical and cosmeceutical grade skin care products actively effect skin at a cellular level, whereas cosmetic products have a shorter-term effect.
Since then, there have been numerous oral NMN supplements on the market. Some clinics specialize in anti-aging therapy and inject NAD+ intravenously to boost the level of NAD+ in the body. Mr. Sinclair is now collaborating with pharmaceutical companies to turn NMN into an approved drug.
And there's even a case study from Turkey in my book of how they have used strictly nontoxic metabolic therapies to remove all of the metastatic cells from this 30-year-old woman. And as long as she was willing to participate and stay on her low-carb diet and have her non-toxic therapies every few months, she stayed clear."
As of 2021, the global statins market was estimated at around $15 billion and is expected to reach $22 billion by 2032. percent reduction—on statin therapy. Many studies are backed by the pharmaceutical and food industries, which can sometimes lead to a conflict of interest, especially when research might contradict their agendas.
As reported by the Consumer Wellness Center (CWC): 2 "The nonprofit Consumer Wellness Center has completed testing of eight popular bone broth and bone broth protein products to determine the possible presence of chemical pesticides, pharmaceuticals, industrial chemicals, toxicological chemicals and food additive chemicals.
Nutraceutical Therapy by Mode of Action We have provided the list below as a summary and followed by a summary explanation and references for each option/nutrient: Vitamin D3 Quercetin Zinc Nigella Sativa (Black Seed Oil) Melatonin Vitamin A Curcumin and Turmeric Vitamin C NAC and Glutathione B Vitamins and NAD+ Probiotics Nattokinase 1.
Food and Drug Administration doesn’t have the authority to regulate dietary supplements before they hit the market. (1) 10 A 2017 study suggested that "efficacious therapies are possible in the foreseeable future." One thing that may make such questions even more complicated is the fact that the U.S.
The first was that the pharmaceutical industry and the FDA recently signaled that drugs for obesity will become the new market investors can expect excellent returns from (this will be discussed in an upcoming article). Likewise, a surprising number of adulterated and spoiled products are on the market.
Rosenberg, MD, is Verrica Pharmaceuticals Inc.s Dr. Rosenberg led the clinical development and approval of Xepi, a topical antibiotic for the treatment of impetigo, at Medimetriks Pharmaceuticals. Rosenberg Named New CMO at Verrica Pharmaceuticals appeared first on The Dermatology Digest. new Chief Medical Officer (CMO).
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content